4.7 Article

Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET

期刊

JOURNAL OF NUCLEAR MEDICINE
卷 50, 期 -, 页码 97S-105S

出版社

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.108.057273

关键词

F-18-FDG PET; cytostatic treatment; cytoreductive therapy; response monitoring; imatinib mesylate

资金

  1. Cancer Research U.K. [C2536/A5708, C37/A5610]
  2. U.K. Medical Research Council [U1200.02.005.00001.01]
  3. MRC [MC_U120081322] Funding Source: UKRI
  4. Cancer Research UK [10337] Funding Source: researchfish
  5. Medical Research Council [MC_U120081322] Funding Source: researchfish

向作者/读者索取更多资源

F-18-FDG PET and, more recently, PET/CT have been established as response biomarkers for monitoring cytotoxic or cytoreductive cancer therapies. With the advent of targeted cancer therapies, which are predominantly cytostatic, F-18-FDG PET is increasingly being used to monitor the therapeutic response to these agents as well. The impressive outcome of F-18-FDG PET studies in patients with gastrointestinal stromal tumors treated with imatinib mesylate brought to the forefront the use of this biomarker for assessing the response to targeted therapies. The use of F-18-FDG PET for this purpose has practical challenges, including quantitative analysis and timing of scans. This review provides a summary of clinical studies of targeted therapies done to date with F-18-FDG PET and provides guidance on practical issues to ensure the optimal interpretation of imaging data in drug development and for patient care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

An Integrated Clinical-MR Radiomics Model to Estimate Survival Time in Patients With Endometrial Cancer

Xingfeng Li, Diana Marcus, James Russell, Eric O. Aboagye, Laura Burney Ellis, Alexander Sheeka, Won-Ho Edward Park, Nishat Bharwani, Sadaf Ghaem-Maghami, Andrea G. Rockall

Summary: A comprehensive model combining features from MRI and clinical variables can improve the estimation of survival time in women with endometrial cancer.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Cardiac & Cardiovascular Systems

Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis

Andrej Corovic, Christopher Wall, Meritxell Nus, Deepa Gopalan, Yuan Huang, Maria Imaz, Michal Zulcinski, Marta Peverelli, Anna Uryga, Jordi Lambert, Dario Bressan, Robert T. Maughan, Charis Pericleous, Suraiya Dubash, Natasha Jordan, David R. Jayne, Stephen P. Hoole, Patrick A. Calvert, Andrew F. Dean, Doris Rassl, Tara Barwick, Mark Iles, Mattia Frontini, Greg Hannon, Roido Manavaki, Tim D. Fryer, Luigi Aloj, Martin J. Graves, Fiona J. Gilbert, Marc R. Dweck, David E. Newby, Zahi A. Fayad, Gary Reynolds, Ann W. Morgan, Eric O. Aboagye, Anthony P. Davenport, Helle F. Jorgensen, Ziad Mallat, Martin R. Bennett, James E. Peters, James H. F. Rudd, Justin C. Mason, Jason M. Tarkin

Summary: This study investigates the feasibility of using somatostatin receptor 2 (SST2) as a molecular imaging target for inflammation in large vessel vasculitis (LVV), and provides evidence for its potential in the diagnosis and therapeutic monitoring of LVV.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Biotechnology & Applied Microbiology

Amplified therapeutic targets in high-grade serous ovarian carcinoma - a review of the literature with quantitative appraisal

Thomas Talbot, Haonan Lu, Eric O. Aboagye

Summary: High-grade serous ovarian carcinoma is characterized by universal TP53 mutations and widespread copy number alterations, including deletion of tumor suppressors and amplification of driver oncogenes. Amplified driver genes have been proposed as therapeutic targets. However, lack of validation and variable experimental procedures hinder clinical translation. This review collates candidate amplified therapeutic targets in high-grade serous ovarian carcinoma and quantitatively appraises the evidence for each gene.

CANCER GENE THERAPY (2023)

Article Oncology

Prediction of Deep Myometrial Infiltration, Clinical Risk Category, Histological Type, and Lymphovascular Space Invasion in Women with Endometrial Cancer Based on Clinical and T2-Weighted MRI Radiomic Features

Xingfeng Li, Michele Dessi, Diana Marcus, James Russell, Eric O. O. Aboagye, Laura Burney Ellis, Alexander Sheeka, Won-Ho Edward Park, Nishat Bharwani, Sadaf Ghaem-Maghami, Andrea G. G. Rockall

Summary: Machine learning classification methods can be used to predict deep myometrial infiltration, clinical risk category, histological type, and lymphovascular space invasion in endometrial cancer. Combining clinical and image signatures can improve the accuracy of these prediction models, which has important implications for patient management.

CANCERS (2023)

Article Cell Biology

Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer

Haonan Lu, Hantao Lou, Georg Wengert, Reema Paudel, Naina Patel, Saral Desai, Bill Crum, Kristofer Linton-Reid, Mitchell Chen, Dongyang Li, Jacey Ip, Francesco Mauri, David J. Pinato, Andrea Rockall, Susan J. Copley, Sadaf Ghaem-Maghami, Eric O. Aboagye

Summary: This study confirms that the presence of tertiary lymphoid structure (TLS) in high-grade serous ovarian cancer (HGSOC) is associated with better progression-free survival (PFS). TLS is linked to B cell maturation and activation of cytotoxic tumor-specific T cells in HGSOC tumors. Copy-number loss of genes IL15 and CXCL10 may hinder TLS formation in HGSOC, and a list of dysregulated genes affecting TLS function is proposed. A radiomics-based signature is developed to predict TLS presence, which independently predicts PFS in HGSOC and non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs). Overall, this study reveals the role of TLS in coordinating immune responses in HGSOC and how the cancer genome evolves to counteract TLS formation.

CELL REPORTS MEDICINE (2023)

Article Oncology

Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

Benjamin Hunter, Christos Argyros, Marianna Inglese, Kristofer Linton-Reid, Ilaria Pulzato, Andrew G. Nicholson, Samuel V. Kemp, Pallav L. Shah, Philip L. Molyneaux, Cillian Mcnamara, Toby Burn, Emily Guilhem, Marcos Mestas Nunez, Julia Hine, Anika Choraria, Prashanthi Ratnakumar, Susannah Bloch, Simon Jordan, Simon Padley, Carole A. Ridge, Graham Robinson, Hasti Robbie, Joseph Barnett, Mario Silva, Sujal Desai, Richard W. Lee, Eric O. Aboagye, Anand Devaraj

Summary: This study developed a radiomics model to assist in the diagnosis of lung cancer. By extracting radiomics features and using clustering methods, patients were stratified into different risk groups. The model showed high accuracy in predicting malignancy and has potential clinical applications.

BRITISH JOURNAL OF CANCER (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Feasibility of [F-18]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study

Shahriar Islam, Marianna Inglese, Matthew Grech-Sollars, Preetha Aravind, Suraiya Dubash, Tara D. Barwick, Kevin O'Neill, James Wang, Azeem Saleem, James O'Callaghan, Giulio Anchini, Matthew Williams, Adam Waldman, Eric O. Aboagye

Summary: MRI and PET are used in neuro-oncology to detect and characterize malignant lesions. In this study, the uptake of FPIA in brain tumors was investigated using PET/MRI.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer

Andrea G. Rockall, Xingfeng Li, Nicholas Johnson, Ioannis Lavdas, Shalini Santhakumaran, A. Toby Prevost, Shonit Punwani, Vicky Goh, Tara D. Barwick, Nishat Bharwani, Amandeep Sandhu, Harbir Sidhu, Andrew Plumb, James Burn, Aisling Fagan, Georg J. Wengert, Dow-Mu Koh, Krystyna Reczko, Qi Dou, Jane Warwick, Xinxue Liu, Christina Messiou, Nina Tunariu, Peter Boavida, Neil Soneji, Edward W. Johnston, Christian Kelly-Morland, Katja N. De Paepe, Heminder Sokhi, Kathryn Wallitt, Amish Lakhani, James Russell, Miriam Salib, Sarah Vinnicombe, Adam Haq, Eric O. Aboagye, Stuart Taylor, Ben Glocker

Summary: The study aimed to develop a machine learning algorithm to improve radiologists' sensitivity and specificity for metastasis detection in whole-body magnetic resonance imaging (WB-MRI). The results showed that using the algorithm can enhance the detection accuracy and reduce reading times for radiologists.

INVESTIGATIVE RADIOLOGY (2023)

Article Chemistry, Multidisciplinary

Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes

Stanislav S. Piletsky, Ekaterina Baidyuk, Elena V. Piletska, Larissa Lezina, Konstantin Shevchenko, Donald J. L. Jones, Thong H. Cao, Rajinder Singh, Alan C. Spivey, Eric O. Aboagye, Sergey A. Piletsky, Nickolai A. Barlev

Summary: Molecularly imprinted polymer nanoparticles (nanoMIPs) have shown potential as an alternative to antibodies in diagnostic and therapeutic applications. Targeting intracellular epitopes can modulate protein function, making them a new tool for cancer therapy.

NANO LETTERS (2023)

Article Oncology

Radiomics and artificial intelligence for precision medicine in lung cancer treatment

Mitchell Chen, Susan J. Copley, Patrizia Viola, Haonan Lu, Eric O. Aboagye

Summary: Lung cancer, the leading cause of cancer-related deaths worldwide, can be captured non-invasively on medical imaging as radiomic features, which can be used in an artificial intelligence paradigm to predict clinical outcomes and improve patient care. Compared to tissue sampling-driven approaches, radiomics-based methods are superior for being non-invasive, reproducible, cheaper, and less susceptible to intra-tumoral heterogeneity.

SEMINARS IN CANCER BIOLOGY (2023)

Letter Medicine, General & Internal

Response to A. Eleuteri regarding A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules

Benjamin Hunter, Catey Bunce, Matthew Blackledge, Eric Aboagye, Richard Lee, LIBRA study

EBIOMEDICINE (2023)

Article Oncology

A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show F-18-Fluorothymidine Flare on Positron Emission Tomography

Preetha Aravind, Sanjay Popat, Tara D. Barwick, Neil Soneji, Mark Lythgoe, Katherina B. Sreter, Jingky P. Lozano-Kuehne, Mattias Bergqvist, Neva Patel, Eric O. Aboagye, Laura M. Kenny

Summary: This study aimed to investigate the early drug action of the antifolate drug pemetrexed on thymidylate synthase (TS) inhibition using F-18-FLT PET/CT imaging. The results showed that patients who exhibited changes in the imaging biomarker had a better therapy response and longer overall survival. These findings suggest the potential use of F-18-FLT PET/CT in understanding the basis of drug action in studies involving TS inhibitors.

CANCERS (2023)

Article Pharmacology & Pharmacy

Evaluation of [18F]AlF-EMP-105 for Molecular Imaging of C-Met

Jin Hui Teh, Ala Amgheib, Ruisi Fu, Chris Barnes, Joel Abrahams, Ali Ashek, Ning Wang, Zixuan Yang, Muneera Mansoorudeen, Nicholas J. J. Long, Eric O. O. Aboagye

Summary: C-Met, a receptor tyrosine kinase overexpressed in various cancer types, has potential as a biomarker for cancer imaging and therapy. This study synthesized and evaluated an [F-18]AlF-labelled analogue, [F-18]AlF-EMP-105, for c-Met imaging using positron emission tomography. In vitro evaluation showed high specificity of [F-18]AlF-EMP-105 for c-Met-expressing cells. PET imaging in mice demonstrated renal clearance of the tracer predominantly as [F-18]fluoride. [F-18]AlF-EMP-105 shows promise as a diagnostic tool for imaging cancer due to its high specificity for c-Met expressing cells.

PHARMACEUTICS (2023)

Article Multidisciplinary Sciences

Non-contrast CT synthesis using patch-based cycle-consistent generative adversarial network (Cycle-GAN) for radiomics and deep learning in the era of COVID-19

Reza Kalantar, Sumeet Hindocha, Benjamin Hunter, Bhupinder Sharma, Nasir Khan, Dow-Mu Koh, Merina Ahmed, Eric O. O. Aboagye, Richard W. W. Lee, Matthew D. D. Blackledge

Summary: Researchers developed a contrast-based CT image synthesis method to address the contrast heterogeneity issue in real-world datasets and evaluated its performance in COVID-19 research. The results showed that while the generated images demonstrated realism in human assessment, caution is advised when using GAN-synthesized images in medical imaging applications.

SCIENTIFIC REPORTS (2023)

Article Chemistry, Multidisciplinary

Automated sulfur-[18F]fluoride exchange radiolabelling of a prostate specific membrane antigen (PSMA) targeted ligand using the GE FASTlab™ cassette-based platform

Zixuan Yang, Chris Barnes, Juozas Domarkas, Joanna Koch-Paszkowski, John Wright, Ala Amgheib, Isaline Renard, Ruisi Fu, Stephen Archibald, Eric O. Aboagye, Louis Allott

Summary: Sulfur-[F-18]fluoride exchange radiochemistry is a rapid and convenient method for incorporating fluorine-18 into biologically active molecules. We reported a fully automated radiolabelling procedure using the GE FASTLab(TM) cassette-based platform to synthesize a [F-18]SO3F-bearing prostate specific membrane antigen (PSMA) targeted ligand ([F-18](5)), which showed favorable biodistribution and pharmacokinetic profiles correlated with PSMA expression.

REACTION CHEMISTRY & ENGINEERING (2023)

暂无数据